Stocktoria
MILESTONE SCIENTIFIC INC. MLSS
NYSE American · XASE · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 1995-11-03
MILESTONE SCIENTIFIC INC. financials (annual, from 10-K)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0M | $8.6M | $9.8M | $8.8M | $10.3M | $5.4M | $8.4M | $9.6M | $11.3M | — |
| Gross profit | $6.4M | $6.4M | $6.8M | $4.9M | $6.3M | $3.6M | $5.7M | $4.4M | $7.0M | $6.3M |
| R&D expense | $449,469 | $858,767 | $701,378 | $1.2M | $878,210 | $307,850 | $189,923 | $245,636 | $272,746 | $1.3M |
| SG&A expense | $11.6M | $12.3M | $13.1M | $12.5M | $12.7M | $10.7M | $9.5M | $10.6M | $11.9M | $11.5M |
| Operating income | -$5.7M | -$6.8M | -$7.1M | -$8.8M | -$7.4M | -$7.5M | -$4.0M | -$8.0M | -$5.2M | -$6.5M |
| Income tax | — | — | $0 | $0 | $333 | $15,500 | $18,126 | $23,986 | $19,093 | -$19,101 |
| Net income | -$5.7M | -$4.7M | -$6.9M | -$8.7M | -$6.8M | -$7.3M | -$7.5M | -$7.4M | -$5.2M | -$5.9M |
| EPS (diluted) | $-0.07 | $-0.06 | — | — | $-0.10 | $-0.12 | $-0.16 | $-0.21 | $-0.16 | $-0.22 |
| Operating cash flow | -$2.9M | -$2.9M | -$5.3M | -$6.0M | -$4.0M | -$7.0M | -$1.8M | -$1.6M | -$1.2M | -$5.4M |
| Free cash flow | -$2.9M | -$2.9M | — | -$6.0M | -$4.0M | -$7.0M | -$1.8M | -$1.6M | -$1.2M | -$5.4M |
| Cash & equivalents | $1.1M | $3.3M | $3.0M | $8.7M | $14.8M | $14.2M | $1.5M | $2.0M | $2.6M | $3.6M |
| Inventory | $3.8M | $3.7M | $2.6M | $1.8M | $1.5M | $2.4M | $1.6M | $1.9M | $3.4M | $4.6M |
| Total assets | $7.8M | $9.8M | $11.4M | $13.7M | $19.8M | $19.6M | $6.6M | $6.4M | $15.6M | $14.2M |
| Total liabilities | $5.0M | $4.0M | $3.4M | $3.7M | $3.6M | $3.5M | $4.9M | $4.9M | $8.1M | $5.6M |
| Shareholders' equity | $2.8M | $5.8M | $8.0M | $10.2M | $16.4M | $16.2M | $1.7M | $1.5M | $7.5M | $8.5M |
Growth · year-over-year · Revenue CAGR -2.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +4.0% | -12.2% | +11.6% | -14.5% | +89.5% | -35.1% | -13.0% | -14.7% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0000855683 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.